Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Biochim Biophys Acta Mol Basis Dis ; 1863(1): 121-128, 2017 01.
Artigo em Inglês | MEDLINE | ID: mdl-27615426

RESUMO

Lysine is catabolized in mammals through the saccharopine and pipecolate pathways - the former is mainly hepatic and renal, and the latter is believed to play a role in the cerebral lysine oxidation. Both pathways lead to the formation of aminoadipic semialdehyde (AASA) that is then oxidized to aminoadipate (AAA) by antiquitin (ALDH7A1). Mutations in the ALDH7A1 gene result in the accumulation of AASA and its cyclic form, piperideine-6-carboxylate (P6C), which causes pyridoxine-dependent epilepsy (PDE). P6C reacts with pyridoxal 5'-phosphate (PLP) causing its inactivation. Here, we used liquid chromatography-mass spectrometry to investigate lysine catabolism in mice injected with lysine labelled at either its nitrogen epsilon (ε-15N) or nitrogen alpha (α-15N). Analysis of ε-15N and α-15N lysine catabolites in plasma, liver and brain suggested the saccharopine as the main pathway for AAA biosynthesis. Although there was evidence for upstream cerebral pipecolate pathway activity, the resulting pipecolate does not appear to be further oxidized into AASA/P6C/AAA. By far the bulk of lysine degradation and therefore, the primary source of lysine catabolites are hepatic and renal. The results indicate that the saccharopine pathway is primarily responsible for body's production of AASA/P6C. The centrality of the saccharopine pathway in whole body lysine catabolism opens new possibilities of therapeutic targets for PDE. We suggest that inhibition of this pathway upstream of AASA/P6C synthesis may be used to prevent its accumulation benefiting PDE patients. Inhibition of the enzyme aminoadipic semialdehyde synthase, for example, could constitute a new strategy to treat PDE and other inherited diseases of lysine catabolism.


Assuntos
Ácido 2-Aminoadípico/metabolismo , Epilepsia/metabolismo , Lisina/análogos & derivados , Lisina/metabolismo , Redes e Vias Metabólicas , Ácido 2-Aminoadípico/análogos & derivados , Animais , Feminino , Camundongos , Camundongos Endogâmicos C57BL , Ácidos Picolínicos/metabolismo , Fosfato de Piridoxal/metabolismo
2.
PLoS One ; 13(8): e0202401, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30133508

RESUMO

OBJECTIVE: To characterize the lipid profile in vaginal discharge of women with vulvovaginal candidiasis, cytolytic vaginosis, or no vaginal infection or dysbiosis. DESIGN: Cross-sectional study. SETTING: Genital Infections Ambulatory, Department of Tocogynecology, University of Campinas, Campinas, São Paulo-Brazil. SAMPLE: Twenty-four women were included in this study: eight with vulvovaginal candidiasis, eight with cytolytic vaginosis and eight with no vaginal infections or dysbiosis (control group). METHODS: The lipid profile in vaginal discharge of the different study groups was determined by liquid chromatography-mass spectrometry and further analyzed with MetaboAnalyst 3.0 platform. MAIN OUTCOME MEASURES: Vaginal lipids concentration and its correlation with vulvovaginal candidiasis and cytolytic vaginosis. RESULTS: PCA, PLS-DA and hierarchical clustering analyses indicated 38 potential lipid biomarkers for the different groups, correlating with oxidative stress, inflammation, apoptosis and integrity of the vaginal epithelial tissue. Among these, greater concentrations were found for Glycochenodeoxycholic acid-7-sulfate, O-adipoylcarnitine, 1-eicosyl-2-heptadecanoyl-glycero-3-phosphoserine, undecanoic acid, formyl dodecanoate and lipoic acid in the vulvovaginal candidiasis group; N-(tetradecanoyl)-sphinganine, DL-PPMP, 1-oleoyl-cyclic phosphatidic, palmitic acid and 5-aminopentanoic acid in the cytolytic vaginosis group; and 1-nonadecanoyl-glycero-3-phosphate, eicosadienoic acid, 1-stearoyl-cyclic-phosphatidic acid, 1-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphate, formyl 9Z-tetradecenoate and 7Z,10Z-hexadecadienoic acid in the control group. CONCLUSIONS: Lipids related to oxidative stress and apoptosis were found in higher concentrations in women with vulvovaginal candidiasis and cytolytic vaginosis, while lipids related to epithelial tissue integrity were more pronounced in the control group. Furthermore, in women with cytolytic vaginosis, we observed higher concentrations of lipids related to bacterial overgrowth.


Assuntos
Apoptose , Candidíase Vulvovaginal , Metabolismo dos Lipídeos , Estresse Oxidativo , Vagina/metabolismo , Adolescente , Adulto , Candidíase Vulvovaginal/diagnóstico , Candidíase Vulvovaginal/metabolismo , Candidíase Vulvovaginal/patologia , Cromatografia Líquida , Estudos Transversais , Citodiagnóstico , Feminino , Humanos , Espectrometria de Massas , Projetos Piloto , Vagina/microbiologia
3.
J Pharm Biomed Anal ; 55(1): 85-92, 2011 Apr 28.
Artigo em Inglês | MEDLINE | ID: mdl-21300511

RESUMO

Galantamine hydrobromide was subjected to different stress conditions (acidic, alkaline, thermal, photolytic and oxidative). Degradation was found to occur under acidic, photolytic and oxidative conditions, while the drug was stable under alkaline and elevated temperature conditions. A stability-indicating reversed-phase liquid chromatographic method was developed for the determination of the drug in the presence of its degradation products. The method was validated for linearity, precision, accuracy, specificity, selectivity and intermediate precision. Additionally, the degradation kinetics of the drug was assessed in relevant cases. The kinetics followed a first order behavior in the case of acidic and photolytic degradation, while a two-phase kinetics behavior was found for the oxidative degradation. The degradation products were characterized by mass spectrometry and nuclear magnetic resonance spectroscopy. Dehydration, epimerization and N-oxidation were the main processes observed during the degradation of galantamine. Moreover, if sufficient material could be isolated the inhibitory activity against the target enzyme acetylcholinesterase was also assessed.


Assuntos
Inibidores da Colinesterase/química , Galantamina/química , Tecnologia Farmacêutica , Doença de Alzheimer/tratamento farmacológico , Inibidores da Colinesterase/análise , Inibidores da Colinesterase/farmacologia , Inibidores da Colinesterase/efeitos da radiação , Colinesterases/metabolismo , Cromatografia Líquida de Alta Pressão , Estabilidade de Medicamentos , Galantamina/análogos & derivados , Galantamina/farmacologia , Galantamina/efeitos da radiação , Temperatura Alta/efeitos adversos , Concentração de Íons de Hidrogênio , Cinética , Luz/efeitos adversos , Espectroscopia de Ressonância Magnética , Oxirredução , Fotólise , Reprodutibilidade dos Testes , Espectrometria de Massas por Ionização por Electrospray , Estereoisomerismo , Espectrometria de Massas em Tandem
4.
J Pharm Biomed Anal ; 52(2): 190-4, 2010 Jun 05.
Artigo em Inglês | MEDLINE | ID: mdl-20133099

RESUMO

A new photoisomer of the promising "anti-Alzheimer" drug candidate (+/-) huperzine A is described. The new substance was formed via a photoisomerization reaction and was found to be 1-amino-13-ethylidene-11-methyl-6-aza-tetracyclo-[7.3.1.0(2.7).0(4.7)]-trideca-2,10-diene-5-one using NMR analysis. The kinetics of its formation was studied and proven to be of first-order. The described photoisomer showed a significant loss in activity, being more than 100 times less active than (-) huperzine A itself. The new substance was named photohuperzine A, referring to its photopyridone substructure.


Assuntos
Inibidores da Colinesterase/química , Inibidores da Colinesterase/metabolismo , Processos Fotoquímicos/efeitos da radiação , Sesquiterpenos/química , Alcaloides , Bioensaio , Calibragem , Cromatografia Líquida , Cinética , Espectrometria de Massas , Estrutura Molecular , Ressonância Magnética Nuclear Biomolecular , Padrões de Referência , Sesquiterpenos/isolamento & purificação , Sesquiterpenos/metabolismo , Espectrofotometria Ultravioleta , Estereoisomerismo , Relação Estrutura-Atividade
5.
J Pharm Biomed Anal ; 53(3): 609-16, 2010 Nov 02.
Artigo em Inglês | MEDLINE | ID: mdl-20466502

RESUMO

The present paper describes a methodology for rapid assessment of chemical and biological degradation products of tacrine and their bioactivity for acetylcholinesterase (AChE). Analysis was achieved by utilizing liquid chromatography coupled to parallel high resolution mass spectrometry and an on-line continuous-flow AChE bioassay for biochemical detection. Key advantage of the strategy described involves the straightforward chemical production of large quantities of products of which many were the same as formed during the biological degradation by cytochromes P450 (CYPs). For this, chemical degradation of tacrine was evaluated under acidic, basic and oxidative conditions as well as elevated temperatures and light exposure. Chemical degradation products were only formed after 2h under reflux with 3% hydrogen peroxide, where more than 50% of tacrine was converted to degradation products. Many of these products showed bioactivity. Mostly, mono-, di- or tri-oxygenated compounds were observed. This study demonstrated that the combination of chemical and biological degradation provides valuable information indicating that assessment of biological activity is important not only for biological degradation products, but also for chemical degradation products when formed. Furthermore, chemical degradation can be used to produce conveniently and in relatively large quantities clean mixtures of compounds that are also produced during metabolic incubations.


Assuntos
Acetilcolinesterase/metabolismo , Tacrina/metabolismo , Acetilcolinesterase/química , Animais , Microssomos Hepáticos/metabolismo , Ratos , Suínos , Espectrometria de Massas em Tandem
6.
Rapid Commun Mass Spectrom ; 22(22): 3662-6, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18946866

RESUMO

Perfume counterfeiting is an illegal worldwide practice that involves huge economic losses and potential consumer risk. EASI is a simple, easily performed and rapidly implemented desorption/ionization technique for ambient mass spectrometry (MS). Herein we demonstrate that EASI-MS allows nearly instantaneous perfume typification and counterfeit detection. Samples are simply sprayed onto a glass rod or paper surface and, after a few seconds of ambient drying, a profile of the most polar components of the perfume is acquired. These components provide unique and reproducible chemical signatures for authentic perfume samples. Counterfeiting is readily recognized since the exact set and relative proportions of the more polar chemicals, sometimes at low concentrations, are unknown or hard to reproduce by the counterfeiters and hence very distinct and variable EASI-MS profiles are observed for the counterfeit samples.


Assuntos
Perfumes/química , Espectrometria de Massas por Ionização por Electrospray/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA